First, no follow-up of participants was performed to confirm COVID-19 disease severity, the study was intended to evaluate the usefulness of these diagnostic tool to yield results in the shortest time and with the greatest efficiency, for this reason the specimens were taken at a single time point without perform a second Ag test that may increase assay sensitivity which represents another limitation. The gene discussed is RENBP; the disease is COVID-19.